Showing results (291-300 of 961) with videos related to

Sort By:
Pageof 97
Ejhaem|September 2, 2022
microRNA expression in acute myeloid leukaemia: New targets for therapy?Daniel Fletcher, Elliott Brown, Julliah Javadala, et al.
Ejhaem|September 2, 2022
The 17-gene stemness score associates with relapse risk and long-term outcomes following allogeneic haematopoietic cell transplantation in acute myeloid leukaemiaDennis D H Kim, Igor Novitzky Basso, Taehyung Simon Kim, et al.
Ejhaem|September 2, 2022
Evaluation of a new ELISA assay for monoclonal free-light chain detection in patients with cardiac amyloidosisHajer Abroud, Asma Beldi-Ferchiou, Vincent Audard, et al.
Ejhaem|September 2, 2022
Dihydroorotate dehydrogenase inhibition acts synergistically with tyrosine kinase inhibitors to induce apoptosis of mantle cell lymphoma cellsMay Eriksen-Gjerstad, Ida Tveit Karlsen, Zinayida Fandalyuk, et al.
Ejhaem|September 2, 2022
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) arising in the setting of polycythemia vera (PV): An illustration of the emerging role of flow cytometry analysis in monitoring progression of myeloproliferative neoplasmsSiba El Hussein, Mariko Yabe, Wei Wang, et al.
Ejhaem|September 2, 2022
Increased prescription rate of anti-infective agents after diagnosis of myelodysplastic syndromesJohanne Rozema, Mels Hoogendoorn, Iris Potma, et al.
Ejhaem|December 15, 2021
The negative impact of the COVID-19 pandemic on UK haematology registrars' well-being and training: Results of a UK nationwide surveyMohammed Oa Altohami, Alexander Langridge, Enas Mk Shareef, et al.
Ejhaem|September 2, 2025
Early Free Light-Chain Suppression as a Prognostic Marker in Relapsed and Refractory Myeloma Patients Treated With BCMA-Directed CAR-T CellsTim Richardson, Hishan Tharmaseelan, Guido Kobbe, et al.
Ejhaem|August 9, 2022
COVID-19-associated secondary hemophagocytic lymphohistiocytosis requiring hematopoietic cell transplantJacob R Greenmyer, Kirk D Wyatt, Sam Milanovich, et al.
Ejhaem|December 5, 2022
Ibrutinib and rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone in patients with previously untreated non-germinal centre B-cell-like diffuse large B-cell lymphoma: A Chinese subgroup analysis of the phase III PHOENIX trialJun Zhu, Xiaonan Hong, Yu Qin Song, et al.
Pageof 97